跳至主要内容
临床试验/NCT03407521
NCT03407521已完成4 期

Measuring Response of Adding Isosorbide Mononitrate to Misoprostol in Induction of Second Trimester Abortion

Ain Shams University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2017年4月12日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
60
试验地点
1
主要终点
induction abortion interval

研究概览

简要总结

the investigators aimed to study the efficacy and safety of nitric oxide donors when combined with prostaglandins in induction of second trimester abortion expecting that both drugs when used together will be of greater efficiency and associated with less side effects.

the study included 60 women with gestational age between 13weeks+0day and 26weeks+6days indicated for pregnancy termination due to maternal or fetal cause.

详细描述

the study aimed to compare the effect of isosorbid mononitrate when combined with misoprostol and misoprostol when used alone in second trimester abortion, expecting that both drugs when used together will be more effective and associated with fewer side effects.

In this study 60 women were enrolled, divided into two groups. The first group (group I), 30 women received misoprostol and isosorbid mononitrate.

The second group (group II), 30 women received misoprostol and placebo. The primary aim of the study was the occurrence of complete abortion in the first 24 hours.

The study concluded that the combination of isosorbid mononitrate with misoprostol is more effective in second trimester abortion than misoprostol with placebo, but is associated with more side effects mainly headache.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
16 Years 至 40 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 16 -40 years
  • Missed abortion
  • Singelton pregnancy
  • Gestationl age between 13 and 26 weeks of pregnancy
  • Normal uterus and cevix on clinical examination
  • Cervix is not dilatated
  • No uterine activity and vaginal bleeding
  • Written and informed consent by the patient
  • Unscarred uterus

排除标准

  • Presence of uterine contraction or bleeding
  • Evidences suggesting of onset of spontaneous abortion as Previous trial to induce abortion
  • Multifetal pregnancy
  • Suspicion of septic abortion
  • History of cervical surgery or manipulation
  • Uterine anomaly
  • IUD in situ
  • Associtaed hemorrhagic disorder
  • History of adverse effects to vaginally adminstered medication
  • Inability to insert vaginal medication high in vagina

研究组 & 干预措施

study group

Active Comparator

misoprostol tab 200mcg 2 tab at first then one every 4 hours with isosorbide mononitrate 20mg once

干预措施: Misoprostol (Drug)

study group

Active Comparator

misoprostol tab 200mcg 2 tab at first then one every 4 hours with isosorbide mononitrate 20mg once

干预措施: isosorbide mononitrate (Drug)

control group

Placebo Comparator

misoprostol tab 200mcg 2 tab at first then one every 4 hours with placebo

干预措施: Misoprostol (Drug)

control group

Placebo Comparator

misoprostol tab 200mcg 2 tab at first then one every 4 hours with placebo

干预措施: Placebo (Drug)

结局指标

主要结局

induction abortion interval

时间窗: 24 hours

time needed to induce abortion in second trimester abortion

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed abd elfatah elsenity

lecturer MD

Ain Shams University

研究点 (1)

Loading locations...

相似试验